Newswok
Semantic Based Sentiment Newspaper
Saturday, September 9, 2017
ARMO BioSciencess Phase 1b Trials Demonstrate Continued Promising Response Rates and Survival in Patients with Advanced Pancreatic Cancer, NSCLC, and RCC
😱 56.3 😐 33.6 😊 7.1
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment